Position in CRMD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$737,413
+$155,436 QoQ
Shares Held
93,938
+9.6% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 194 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. CRMD ranks #157 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in CRMD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $737,413 | 93,938 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $581,977 | 85,711 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,001,075 | 86,077 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,111,269 | 95,552 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,144,589 | 92,905 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $502,440 | 81,565 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $613,550 | 75,747 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $563,329 | 69,719 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $321,454 | 74,239 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $266,696 | 62,900 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $258,996 | 68,882 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $209,775 | 56,696 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $196,733 | 49,555 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $231,973 | 42,331 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $197,237 | 43,349 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $201,605 | 43,356 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $295,247 | 43,039 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $245,264 | 24,551 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $196,308 | 26,421 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $122,650 | 20,340 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $154,066 | 24,455 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $69,868 | 19,462 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||